• Murine RNase Inhibitor: Precision RNA Protection in RT-PCR W

  2026-05-20

  Murine RNase Inhibitor K1046 from APExBIO delivers industry-leading, oxidation-resistant RNA protection—especially vital for advanced real-time RT-PCR and in vitro transcription. Its unique murine recombinant design ensures robust RNA integrity in even the lowest DTT conditions, enabling researchers to achieve consistent results in sensitive, high-throughput workflows.

• XAV-939 in Translational Disease Modeling: Precision Wnt Mod

  2026-05-20

  Explore how XAV-939 (NVP-XAV939) powers next-generation translational research through targeted Wnt/β-catenin pathway inhibition. This in-depth guide offers unique insights into protocol design, disease modeling, and mechanistic interpretation in oncology, fibrosis, and regenerative studies.

• GCG Disrupts SARS-CoV-2 Nucleocapsid Phase Separation: Mecha

  2026-05-19

  This study uncovers how SARS-CoV-2 nucleocapsid protein undergoes RNA-triggered liquid–liquid phase separation (LLPS), a process essential for viral replication and assembly. The authors demonstrate that the natural compound (-)-gallocatechin gallate (GCG) inhibits viral replication by disrupting this critical condensation process, offering a potential new antiviral strategy.

• Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea): From Photo

  2026-05-19

  Diuron, a benchmark photosynthesis inhibitor, is redefining toxicology research through its newly uncovered mechanisms of nephrotoxicity. This article translates the latest network toxicology and experimental validation data into actionable workflows, troubleshooting strategies, and cross-domain applications for plant biology and environmental health scientists.

• Cell-Surface LAMP1 as a Senescence Marker in Lung Aging and

  2026-05-18

  This study identifies cell-surface LAMP1 as a robust and selective biomarker for cellular senescence in both aging and idiopathic pulmonary fibrosis. By validating LAMP1 enrichment across species and tissue types and demonstrating its utility in targeted antibody-drug conjugate strategies, the work advances the field's ability to detect and eliminate senescent cells with precision.

• Ertugliflozin (PF-04971729): Optimizing SGLT2 Assays & Appli

  2026-05-18

  Ertugliflozin (PF-04971729) delivers unmatched selectivity and reproducibility for SGLT2-mediated glucose transport studies, supporting advanced diabetes and renal research. This guide breaks down actionable protocols, troubleshooting strategies, and recent literature insights for maximizing bench-to-publication success.

• (+)-Bicuculline: Technical Use Guide for GABAA Antagonism

  2026-05-17

  (+)-Bicuculline is a classical GABAA receptor antagonist used to interrogate inhibitory neurotransmission and synaptic NMDA receptor signaling in neuroscience workflows. This reagent enables controlled dissection of GABAergic pathways but is not intended for diagnostic, clinical, or therapeutic applications. Its effective use requires strict adherence to solubility and storage protocols to ensure experimental reproducibility.

• High-Throughput BBB Model: Integrating LLC-PK1-MDR1 and Lyso

  2026-05-16

  This study presents a high-throughput in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK and LLC-PK1-MDR1 cells, integrating a correction for lysosomal trapping—an often-overlooked factor affecting drug permeability predictions. The model demonstrates strong predictive accuracy for CNS drug distribution and offers practical improvements for early-stage drug screening.

• MK-4827 (Niraparib): Redefining DNA Repair Inhibition Strate

  2026-05-15

  Explore the advanced science of MK-4827 (Niraparib), a selective PARP-1/-2 inhibitor, and its transformative role in cancer research through precision DNA damage repair inhibition. This article uniquely bridges molecular mechanism, translational insights, and protocol decision-making for BRCA-mutant and proficient models.

• Baicalin Methyl Ester: Applied Workflows for Intestinal Barr

  2026-05-15

  Baicalin methyl ester, an esterified derivative of baicalin, sets a new benchmark for reproducibility and mechanistic clarity in LPS-induced intestinal barrier damage research. This guide translates cutting-edge findings into actionable protocols and troubleshooting strategies for both in vitro and in vivo intestinal inflammation models.

• Deracoxib and Piroxicam: Antiproliferative Effects in Canine

  2026-05-14

  This study systematically evaluates the antiproliferative and pro-apoptotic effects of deracoxib, a selective COX-2 inhibitor, alone and in combination with piroxicam on canine mammary carcinoma cells. The findings highlight the potential for combinatorial NSAID regimens to enhance apoptosis and cell cycle arrest in veterinary oncology models.

• Phenothiazines Boost Macrophage Antibacterial Defense via RO

  2026-05-14

  This study demonstrates that phenothiazines, including Perphenazine, enhance the antibacterial capacity of macrophages by inducing reactive oxygen species (ROS) and autophagy, independent of direct antibacterial action. These findings establish a host-directed therapeutic mechanism with implications for combating antibiotic-resistant intracellular pathogens.

• WY-14643 (Pirinixic Acid): Translational Leverage in PPARα R

  2026-05-13

  This thought-leadership article explores the mechanistic and strategic dimensions of WY-14643 (Pirinixic Acid) as a selective PPARα agonist. Integrating novel insights from multi-omics tumor studies with established metabolic disorder research, it provides translational researchers with actionable guidance on harnessing WY-14643 for dissecting lipid metabolism, anti-inflammatory signaling, and tumor microenvironment modulation. The article situates APExBIO’s WY-14643 within the evolving competitive landscape, offers rigorously sourced protocol parameters, and concludes with a forward-looking outlook grounded in current evidence.

• Zolmitriptan: 5-HT1B Receptor Agonist for Migraine Research

  2026-05-13

  Zolmitriptan is a potent 5-HT1B receptor agonist used in migraine and cluster headache research. It demonstrates high selectivity and reproducible solubility in DMSO and ethanol, enabling robust experimental workflows.

• Acetylcysteine: Mechanistic Basis and Benchmarking in Redox

  2026-05-12

  Acetylcysteine (N-acetyl-L-cysteine) is a validated antioxidant precursor for glutathione biosynthesis, widely used to modulate oxidative stress pathways and chemoresistance in disease models. This article details mechanistic, benchmark, and protocol evidence for its use in advanced biomedical research.

16414 records 1/1095 page Next 12345 下5页 Last page